Skip to main content

Table 6 Cardiac Index (L min−1)

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 Terlipressin group (n = 50)Placebo group (n = 50)P value
Baseline2.49 ± 0.822.67 ± 0.850.2838
0 min2.39 ± 1.533.47 ± 1.510.0006*
10 min2.43 ± 1.483.25 ± 1.430.0059*
20 min2.47 ± 1.563.24 ± 1.490.0132*
30 min2.48 ± 1.473.13 ± 1.520.0321*
40 min2.51 ± 1.513.19 ± 1.570.0296*
50 min2.56 ± 1.533.16 ± 1.490.0498*
60 min2.52 ± 1.483.2 ± 1.550.0271*
  1. Baseline reading before skin incision
  2. Minutes after weaning from cardiopulmonary bypass
  3. Mean ± SD
  4. *P value is significant when P < 0.05
\